Avoralstat
Cat. No.:YN481560
产品名称: | Avoralstat |
CAS No.: | 918407-35-9 |
Chemical Name: | 3-[2-[[[4-(aminoiminomethyl)phenyl]amino]carbonyl]-4-ethenyl-5-methoxyphenyl]-6-[[(cyclopropylmethyl)amino]carbonyl]-2-pyridinecarboxylic acid |
Synonyms: | BCX4161 |
分子量: | 513.54 |
分子式: | C₂₈H₂₇N₅O₅ |
SMILES: | O=C(C1=NC(C(NCC2CC2)=O)=CC=C1C3=CC(OC)=C(C=C)C=C3C(NC4=CC=C(C(N)=N)C=C4)=O)O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Avoralstat (BCX4161) 是一种有效的,具有口服活性的血浆激肽释放酶(PKK)抑制剂,用于研究遗传性血管性水肿。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Cornpropst, M., Collis, P., Collier, J., et al.Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: Phase 1 studyAllergy71(12),1676-1683(2016)
Sun, Y.J., Velez, G., Parsons, D.E., et al.Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in miceJ. Clin. Invest.131(10),e147973(2021)
Hu, X., Shrimp, J.H., Guo, H., et al.Discovery of TMPRSS2 inhibitors from virtual screening as a potential treatment of COVID-19ACS Pharmacol. Transl. Sci.4(3),1124-1135(2021)